Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Change in Cash (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Change in Cash for 3 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Cash rose 107.62% year-over-year to $1.2 million; the TTM value through Dec 2025 reached -$13.3 million, changed 0.47%, while the annual FY2025 figure was -$13.3 million, 0.47% changed from the prior year.
  • Change in Cash hit $1.2 million in Q4 2025 for Artiva Biotherapeutics, up from -$3.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $21.6 million in Q3 2024 and bottomed at -$15.6 million in Q4 2024.
  • Average Change in Cash over 3 years is -$2.7 million, with a median of -$4.1 million recorded in 2024.
  • On a YoY basis, Change in Cash climbed as much as 107.62% in 2025 and fell as far as 113.68% in 2025.
  • Artiva Biotherapeutics' Change in Cash stood at -$12.4 million in 2023, then dropped by 26.37% to -$15.6 million in 2024, then skyrocketed by 107.62% to $1.2 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $1.2 million, -$3.0 million, and -$1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.